Compounds > cp-55,940
Page last updated: 2024-08-26

cp-55,940 and nabilone

cp-55,940 has been researched along with nabilone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Attali, A; Duursma, A; Lange, JH; Mulder, A; van Aken, HH; van der Neut, MA; van Vliet, BJ; Wals, HC; Zilaout, H1
Buzard, DJ; Han, S; Jones, RM; Thatte, J1
Bohn, LM; Brust, CA; Georgiadis, MO; Iliopoulos-Tsoutsouvas, C; Ji, L; Ma, X; Makriyannis, A; Nikas, SP; Papanastasiou, IP; Paronis, CA; Tong, F; Tran, NK; Wood, JT; Zvonok, N1

Reviews

1 review(s) available for cp-55,940 and nabilone

ArticleYear
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
    Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21

    Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity

2013

Other Studies

2 other study(ies) available for cp-55,940 and nabilone

ArticleYear
Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists.
    Bioorganic & medicinal chemistry letters, 2010, Sep-01, Volume: 20, Issue:17

    Topics: Pyrazoles; Receptor, Cannabinoid, CB1

2010
Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.
    European journal of medicinal chemistry, 2022, Feb-15, Volume: 230

    Topics: Dronabinol; Receptor, Cannabinoid, CB1; Structure-Activity Relationship

2022